Atlas Trials

A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT05320146 · COMPLETED

Trial details

NCT number
NCT05320146
Sponsor
Corcept Therapeutics
Status
COMPLETED
Study type
OBSERVATIONAL
Nonalcoholic Steatohepatitis (NASH)
Start date
2022-03-04
Primary completion
2023-07-18
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.